Respiratory multiplex PCR and antimicrobial treatment modification in hospitalized patients with community-acquired pneumonia
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 22.07.2026. Verfasst von Hülya Çaşkurlu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Türkiye. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Community-acquired pneumonia (CAP) is a major cause of hospitalization, and pathogen identification is often limited by low diagnostic yield of conventional microbiological methods. Respiratory multiplex PCR (mPCR) enables rapid pathogen detection, but its role in antimicrobial treatment modification for inpatients with CAP remains unclear. This study evaluated the association between mPCR testing and antimicrobial modification in hospitalized patients with CAP.
Methods
This retrospective, single center cohort study included hospitalized patients with CAP identified using ICD-10 codes between July 2023 and February 2025. Respiratory mPCR was performed within the first 24 hours of admission using combined nasopharyngeal/oropharyngeal (NP/OP) swabs. The primary outcome was antimicrobial treatment modification guided by mPCR results and documented by physicians. Secondary outcomes included antimicrobial de-escalation and hospital length of stay.
Results
In this cohort of 145 patients, mPCR detected a pathogen in 56 patients (38.6%): viral pathogens in 30 (20.7%) and bacterial pathogens in 26 (17.9%). Overall antimicrobial treatment was modified in 54 patients (37.2%). Modification guided by mPCR results and documented by physicians occurred in 37 patients (25.5%). Among these 37 modifications, 35 (94.6%) were classified as antimicrobial de-escalation. Hospital length of stay did not differ significantly across mPCR results.
Conclusions
In hospitalized patients with CAP, mPCR facilitates targeted antimicrobial treatment modification and drives high rates of de-escalation. These findings demonstrate the significant utility of mPCR in optimizing clinical decisions and enhancing antimicrobial stewardship.
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Türkiye.
- Department of Medical Microbiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Türkiye.
ORCID-Profile: Hülya Çaşkurlu, Halenur Vural Akbal, Hatice Kübra Uçar, Esra Koçoğlu, Özlem Aydın, Pınar Ergen, Yasemin Çağ
Zitieren
APA
Çaşkurlu, H., Vural Akbal, H., Uçar, H. K., Koçoğlu, E., Aydın, Ö., Ergen, P., & Çağ, Y. (2026). Respiratory multiplex PCR and antimicrobial treatment modification in hospitalized patients with community-acquired pneumonia. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10760
Vancouver
Çaşkurlu H, Vural Akbal H, Uçar HK, Koçoğlu E, Aydın Ö, Ergen P, et al. Respiratory multiplex PCR and antimicrobial treatment modification in hospitalized patients with community-acquired pneumonia. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10760
BibTeX
@article{akurlu2026,
author = {Çaşkurlu, Hülya and Vural Akbal, Halenur and Uçar, Hatice Kübra and Koçoğlu, Esra and Aydın, Özlem and Ergen, Pınar and Çağ, Yasemin},
title = {Respiratory multiplex PCR and antimicrobial treatment modification in hospitalized patients with community-acquired pneumonia},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10760}
}
EUVIMED